Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma
Open Access
- 9 September 2016
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoImmunology
- Vol. 5 (11), e1234565
- https://doi.org/10.1080/2162402x.2016.1234565
Abstract
Kupffer cells represent the first line of defense against tumor cells in the liver. Myeloid-derived suppressor cells (MDSC) have recently been observed in the liver parenchyma of tumor-bearing animals. The present study investigates the function of the MDSC subsets, and their impact on Kupffer cell phenotype and function. RIL-175 mouse hepatocellular carcinoma (HCC) cells were injected into the median liver lobe of C57BL/6 mice. Three weeks later, the median lobe hosting the tumor nodule was removed, and Kupffer cells and MDSCs were sorted from the remaining liver. Mouse livers devoid of HCC served as control. Kupffer cells expressed less co-stimulatory CD86 and MHCII and more co-inhibitory CD274 molecules in HCC-bearing livers than in control livers. Corresponding to this phenotype, Kupffer cells from HCC-bearing mice were less efficient in their function as antigen-presenting cells. Three CD11b+ cell populations were identified and sorted from HCC-bearing mice. These cells had various phenotypes with different levels of MDSC-specific surface markers (Ly6Ghigh cells, Gr1high cells, and Ly6Clow cells), and may be considered as bonafide MDSCs given their suppression of antigen-specific T cell proliferation. Primary isolated Kupffer cells in co-culture with the three MDSC subsets showed a decrease in CCL2 and IL-18 secretion, and an increase in IL-10 and IL-1β secretion, and an increased expression of CD86, CD274, and MHCII. In conclusion, these data demonstrated the existence of three MDSC subsets in HCC-bearing animals. These cells altered Kupffer cell function and may decrease the migration and activation of anticancer effector cells in the liver.Keywords
This publication has 46 references indexed in Scilit:
- Targeting tumor-associated myeloid cells for cancer immunotherapyOncoImmunology, 2015
- Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacyOncoImmunology, 2015
- Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extractCancer Immunology, Immunotherapy, 2013
- Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing miceJournal of Leukocyte Biology, 2012
- Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationshipImmunological Investigations, 2012
- Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in miceJournal of Hepatology, 2010
- Kupffer cells in non-alcoholic fatty liver disease: The emerging viewJournal of Hepatology, 2009
- Kupffer cell heterogeneity: functional properties of bone marrow–derived and sessile hepatic macrophagesBlood, 2007
- Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 ResponsePublished by The American Association of Immunologists ,2007
- Activation of Kupffer cells inhibits tumor growth in a murine model systemInternational Journal of Cancer, 2002